Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Background. Contrast-induced nephropathy (CIN) limits the outcome of percutaneous coronary intervention (PCI). Objective. To investigate whether pretreatment with Compound Danshen Dripping Pills (CDDP) will decrease the incidence of CIN after PCI. Methods. A total of 229 patients with acute coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rong, Chang, Liang, Guo, Bing-yan, Wang, Yan-wei, Wang, Ya-ling, Jin, Xin, Liu, Su-yun, Li, Yong-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216665/
https://www.ncbi.nlm.nih.gov/pubmed/25386219
http://dx.doi.org/10.1155/2014/256268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216665/
https://www.ncbi.nlm.nih.gov/pubmed/25386219
http://dx.doi.org/10.1155/2014/256268

Ejemplares similares